Bölge seçiniz

Haber akışımıza abone olun

Abone ol

Bir soru?

Bize Ulaşın

2.06.2026

Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting

Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge’s EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures.

Basın bülteni

2.06.2026
Getinge Launches Vasoview Hemopro 3, Advancing Endoscopic Vessel Harvesting

Getinge today announced the launch of the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System, including the Hemopro 3 Harvesting Tool and dedicated Hemopro 3 Power Supply. Designed for clinicians, by clinicians, the system represents the latest evolution of Getinge’s EVH platform, enhancing decades of experience supporting coronary artery bypass grafting (CABG) procedures.
28.05.2026

Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc (“Abiomed”) in a patent dispute between Getinge’s subsidiary Maquet Cardiovascular LLC (“Maquet”) and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.

Basın bülteni

28.05.2026
Getinge’s subsidiary Maquet Cardiovascular receives adverse jury trial verdict in patent infringement dispute with Abiomed in the U.S.

Getinge today announces that a jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed Inc (“Abiomed”) in a patent dispute between Getinge’s subsidiary Maquet Cardiovascular LLC (“Maquet”) and Abiomed. The jury found that Abiomed has not infringed any Maquet patents relating to intravascular heart pump technology.
21.04.2026

Resolutions at Getinge’s Annual General Meeting April 21, 2026

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.

Düzenleyici

21.04.2026
Resolutions at Getinge’s Annual General Meeting April 21, 2026

Getinge AB (publ)’s Annual General Meeting (“AGM”) was held on April 21, 2026 in Kongresshallen, Hotel Tylösand, Halmstad, Sweden. At the AGM, the following was resolved.
21.04.2026

Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone

“We succeeded in surpassing last year’s record-breaking first quarter with organic growth in both net sales and order intake,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 0,8% while the order intake rose by 3,9% organically.

Düzenleyici

21.04.2026
Getinge Interim Report January-March 2026: Organic growth, strong cash flow and regulatory milestone

“We succeeded in surpassing last year’s record-breaking first quarter with organic growth in both net sales and order intake,” says Mattias Perjos, President & CEO at Getinge. The medtech company’s net sales increased organically by 0,8% while the order intake rose by 3,9% organically.
7.04.2026

Getinge invites fund managers, analysts, and media to Q1 Report 2026 conference call

Getinge will issue its Q1 Report 2026 on April 21, 2026, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.

Basın bülteni

7.04.2026
Getinge invites fund managers, analysts, and media to Q1 Report 2026 conference call

Getinge will issue its Q1 Report 2026 on April 21, 2026, at 12.00 p.m. CEST, followed by a conference call at 13:00 p.m. CEST, hosted by Mattias Perjos, President & CEO, and Agneta Palmér, CFO.
26.03.2026

Getinge publishes Annual Report for 2025

Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underlying profitability, continued regulatory progress, and an ambitious innovation agenda.

Düzenleyici

26.03.2026
Getinge publishes Annual Report for 2025

Today, Getinge publishes its Annual Report for 2025, including the Sustainability statement. The year was marked by geopolitical friction and significant cost impacts from tariffs and currency movements, while the company delivered strong underlying profitability, continued regulatory progress, and an ambitious innovation agenda.

Basın iletişim

Caroline Örmgård, Getinge Head of Public & Media Relations

Caroline Örmgård

Head of Public & Media Relations
Phone: +46 10 335 0041

Email
Lars Mattsson, Getinge

Lars Mattsson

Senior Vice President Enterprise Development
Phone: +46 10 335 0043

Email
Katarzyna Sypula,Senior CX Campaigns & Events Manager, Getinge

Katarzyna Sypuła

Senior Customer Experience Campaigns & Events Manager 
CEE/ South Europe / SAPAC
Tel: +48 661 705 706

Email
Newsroom2

Bizimle çevrimiçi iletişime geçmeyi mi tercih ediyorsunuz?

Uygun formu doldurmak için aşağıya tıklayın. Yakında sizinle iletişime geçeceğiz!

Formu doldurun

Mı arıyorsun

Getinge Hybrid OR

Resim Galerisi

Basın makalesi amacıyla kullanıma sunulan çeşitli resim formatı

Galeriye git
Man and woman looking a something together

Hakkımızda

Bir bakışta Getinge hakkında bilmeniz gereken her şey

Getinge hakkında daha fazla bilgi edinin
Cardiosave

Acil Tıbbi Cihaz Düzeltmesi

CARDIOSAVE intra-aortik balon pompası (IABP) için Gönüllü Acil Tıbbi Cihaz Saha Düzeltmesi

Bildirimi okuyun
Newsroom

Hiçbir şeyi kaçırma

Simgelere tıklayın ve bizi takip edin!

 

     

Şu anda Getinge.com'dan ayrılıyorsunuz. Getinge ekibi tarafından yönetilmeyen içeriğe erişebilirsiniz, bu durumda Getinge içerikten sorumlu tutulamaz. 

Anlıyorum!